210 related articles for article (PubMed ID: 11845162)
21. European Commission dips toe into military research.
Willerroider M
Nature; 2003 Oct; 425(6958):549. PubMed ID: 14534553
[No Abstract] [Full Text] [Related]
22. Science policy. Caught in the squeeze.
Mervis J
Science; 2005 Feb; 307(5711):832-4. PubMed ID: 15705818
[No Abstract] [Full Text] [Related]
23. Protest letter accuses health agency of biodefence bias.
Check E
Nature; 2005 Mar; 434(7029):7. PubMed ID: 15744263
[No Abstract] [Full Text] [Related]
24. Security worries stifle report on agricultural bioterror.
Gewin V
Nature; 2002 Sep; 419(6903):99. PubMed ID: 12226623
[No Abstract] [Full Text] [Related]
25. US report pins down future biosecurity.
Wadman M
Nature; 2010 Aug; 466(7307):678. PubMed ID: 20686545
[No Abstract] [Full Text] [Related]
26. Biomedical research--an integral component of national security.
Hirschberg R; La Montagne J; Fauci AS
N Engl J Med; 2004 May; 350(21):2119-21. PubMed ID: 15152055
[No Abstract] [Full Text] [Related]
27. Buying biosafety--is the price right?
Richardson L
N Engl J Med; 2004 May; 350(21):2121-3. PubMed ID: 15152056
[No Abstract] [Full Text] [Related]
28. Biomedical funding remains flat.
Check E
Nature; 2006 Feb; 439(7077):644. PubMed ID: 16496450
[No Abstract] [Full Text] [Related]
29. Funding agendas: has bioterror defense been over-prioritized?
May T
Am J Bioeth; 2005; 5(4):34-44. PubMed ID: 16109694
[TBL] [Abstract][Full Text] [Related]
30. Fight against terror 'needs science institute'.
Check E
Nature; 2002 Jun; 417(6892):887. PubMed ID: 12087368
[No Abstract] [Full Text] [Related]
31. Obstacles to biodefence.
Nature; 2002 Sep; 419(6902):1. PubMed ID: 12214191
[No Abstract] [Full Text] [Related]
32. Finding a space for the public's health in bioterrorism funding: a commentary.
Gostin LO
Am J Bioeth; 2005; 5(4):45-7. PubMed ID: 16109695
[No Abstract] [Full Text] [Related]
33. Cost/success projections for US biodefense countermeasure development.
Matheny J; Mair M; Smith B
Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
[No Abstract] [Full Text] [Related]
34. Statement on the consideration of biodefence and biosecurity.
Atlas R; Campbell P; Cozzarelli NR; Curfman G; Enquist L; Fink G; Flanagin A; Fletcher J; George E; Hammes G; Heyman D; Inglesby T; Kaplan S; Kennedy D; Krug J; Levinson R; Marcus E; Metzger H; Morse SS; O'Brien A; Onderdonk A; Poste G; Renault B; Rich R; Rosengard A; Salzberg S; Scanlan M; Shenk T; Tabor H; Varmus H; Wimmer E; Yamamoto K;
Nature; 2003 Feb; 421(6925):771. PubMed ID: 12594463
[No Abstract] [Full Text] [Related]
35. Issues in biosecurity and biosafety.
Cook-Deegan RM; Berkelman R; Davidson EM; Finder S; Heitman E; Kelley MC; King NM; Moseley R; Thomas JC; Tilden SJ; Vangsnes NM
Science; 2005 Jun; 308(5730):1867-8. PubMed ID: 15976287
[No Abstract] [Full Text] [Related]
36. Senators call for biodefence boost.
Knight J
Nature; 2001 Oct; 413(6855):441. PubMed ID: 11586309
[No Abstract] [Full Text] [Related]
37. Plans to step up bioterrorism research via the NIH.
Cimons M
Nat Med; 2002 Jan; 8(1):6. PubMed ID: 11786885
[No Abstract] [Full Text] [Related]
38. Confronting terrorism. One year after: hunt for NIH funds fosters collaboration.
Enserink M
Science; 2002 Sep; 297(5587):1630-1. PubMed ID: 12215622
[No Abstract] [Full Text] [Related]
39. U.S. budget. Spending triples on terrorism R&D.
Malakoff D
Science; 2002 Jan; 295(5553):254. PubMed ID: 11786619
[No Abstract] [Full Text] [Related]
40. Cell therapy and homeland security: funding opportunities for biomedical research.
Marty PJ; Sanberg PR; Daugherty RM
Cell Transplant; 2003; 12(6):553-4. PubMed ID: 14579922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
